Question 1

What are the most cited papers from Modulation Therapeutics (United States)?

Accepted Answer

The most cited paper from Modulation Therapeutics (United States) is "A Multicenter, Prospective Trial to Assess the Safety and Performance of the Spinal Modulation Dorsal Root Ganglion Neurostimulator System in the Treatment of Chronic Pain" (Liong Liem, Marc A. Russo, Frank J.P.M. Huygen et al., 2013), with 241 citations. Next come "One-Year Outcomes of Spinal Cord Stimulation of the Dorsal Root Ganglion in the Treatment of Chronic Neuropathic Pain" (228) and "A Prospective Study of Dorsal Root Ganglion Stimulation for the Relief of Chronic Pain" (217).

Question 2

Which research topics does Modulation Therapeutics (United States) publish most on?

Accepted Answer

By volume in 2022-now: PARP inhibition in cancer therapy, Phosphodiesterase function and regulation, Cholinesterase and Neurodegenerative Diseases and Phytochemistry and biological activities of Ficus species.

Question 3

Which keywords describe research at Modulation Therapeutics (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunotherapy, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies, PET Imaging and Targeted Therapy.

Question 4

Which fields of science does Modulation Therapeutics (United States) work in?

Accepted Answer

In all years, 46% of research at Modulation Therapeutics (United States) is in Life Sciences, 40% in Health Sciences. Its largest fields are Medicine (39%), Biochemistry, Genetics and Molecular Biology (37%), Computer Science (4%). It does 2.6× the world's share of Life Sciences.

Question 5

Is Modulation Therapeutics (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 38% higher than in 2018-2021.